<- Go Home
Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. develops novel antibiotics. It provides XERAVA for the treatment of complicated intra-abdominal infections caused by susceptible microorganisms. The company was incorporated in 2006 and is based in Waltham, Massachusetts. Tetraphase Pharmaceuticals, Inc. operates as a subsidiary of La Jolla Pharmaceutical Company.
Market Cap
$16.1M
Volume
569.8K
Cash and Equivalents
$15.4M
EBITDA
-$48.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$21.4M
Profit Margin
259.11%
52 Week High
$8.60
52 Week Low
$0.56
Dividend
N/A
Price / Book Value
0.96
Price / Earnings
-0.29
Price / Tangible Book Value
1.28
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$49.2M
Return on Equity
175.72%
Return on Assets
-52.18
Cash and Short Term Investments
$15.4M
Debt
$4.7M
Equity
$16.6M
Revenue
$8.3M
Unlevered FCF
-$32.2M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium